You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GLP1 agonist

Showing 1 - 25 of 6,572
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double Diabetes Trial in Dijon (Insulin + semaglutide treatment, Usual insulin treatment, Biological check-up)

Recruiting
  • Double Diabetes
  • Insulin + semaglutide treatment
  • +2 more
  • Dijon, France
    Chu Dijon Bourgogne
Jul 18, 2022

Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)

Recruiting
  • Obesity
  • POSE2.0 Endoscopic Gastric Remodeling
  • Liraglutide injection
  • Ras al-Khaimah, United Arab Emirates
    Ibrahim Bin Hamad Obaidullah Hospital
Jan 27, 2023

Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)

Recruiting
  • Cystic Fibrosis
  • +3 more
  • Dulaglutide 0.75Mg/0.5Ml Inj Pen
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 11, 2023

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis-related Diabetes
  • Minneapolis, Minnesota
    University of Minnesota
Mar 15, 2023

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Alcohol Use Disorder Trial in Boston (Exenatide, Sham injection)

Terminated
Has Results
  • Alcohol Use Disorder
  • Boston, Massachusetts
    Boston University Psychiatry Research Center, Clinical Studies U
Jan 14, 2022

Liver Transplant; Complications, Diabetes, NASH - Nonalcoholic Steatohepatitis Trial (Semaglutide Treatment, Sitagliptin 100mg)

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • Semaglutide Treatment
  • Sitagliptin 100mg
  • (no location specified)
Jun 17, 2022

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Safety and Tolerability Trial in Neuss (ZP7570, Placebo)

Not yet recruiting
  • Safety and Tolerability
  • Neuss, North Rhine-Westphalia, Germany
    Profil Institut für Stoffwechselforschung GmbH
Aug 18, 2023

Diabetes, Type 2 Trial in Washington (Semaglutide, Placebos)

Recruiting
  • Diabetes Mellitus, Type 2
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Type 2 Diabetes Trial in Xuzhou (GLP-1 receptor agonist)

Recruiting
  • Type 2 Diabetes Mellitus
  • GLP-1 receptor agonist
  • Xuzhou, Jiangsu, China
    Department of Endocrinology
Apr 16, 2022

Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)

Active, not recruiting
  • Healthy
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Nov 22, 2022

Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

Recruiting
  • Ischemic Stroke
  • Herlev, Denmark
    Department of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022

Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

Recruiting
  • Osteoporosis, Postmenopausal
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Jackson, Mississippi
    University of Mississippi Medical Center
Aug 5, 2022

Comparative Effectiveness of Empagliflozin in the US

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Boston, Massachusetts
    Bringham Women Hospital
Jan 9, 2023

Obesity, Aging Trial (Semaglutide Pen Injector)

Not yet recruiting
  • Obesity
  • Aging
  • Semaglutide Pen Injector
  • (no location specified)
May 4, 2022

Coronary Disease, Shock, Cardiogenic, Renal Failure Trial in Copenhagen (Byetta (Lilly, Exenatide), Conoxia (AGA, oxygen), 20%

Recruiting
  • Coronary Disease
  • +5 more
  • Byetta (Lilly, Exenatide)
  • +2 more
  • Copenhagen, Denmark
    Rigshospitalet - Copenhagen University Hospital
Apr 15, 2021

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS ,

Active, not recruiting
  • Weight Loss
  • +3 more
  • GLP-1 receptor agonist
  • Culleredo, A Coruña, Spain
  • +10 more
Jan 13, 2023